Food supplements with red yeast rice: More regulations are needed

Abstract

Get full access to this article

View all access options for this article.

References

Jiang

Jia

et al.

A meta-analysis of red yeast rice: An effective and relatively safe alternative approach for dyslipidemia. PloS One 2014; 9: e98611, 1–10.

Gerards

Terlou

et al.

Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis. Atherosclerosis 2015; 240: 415–423.

Burke

. Red yeast rice for the treatment of dyslipidemia. Curr Atheroscler Rep 2015; 17: 495–495.

Cohen

Avula

Khan

. Variability in strength of red yeast rice supplements purchased from mainstream retailers. Eur J Prev Cardiol 2017; 24: 1431–1434.

Gordon

Cooperman

Obermeyer

et al.

Marked variability of monacolin levels in commercial red yeast rice products. Arch Intern Med 2010; 170: 1722–1727.

Herber

Lembertas

et al.

An analysis of nine proprietary Chinese red yeast rice dietary supplements: Implications of variability in chemical profile and contents. J Altern Complement Med 2001; 7: 133–139.

Song

El-Demerdash

Lee

Smith

. Fast screening of lovastatin in red yeast rice products by flow injection tandem mass spectrometry. J Pharm Biomed Anal 2012; 57: 76–81.

Superior Health Council of Belgium. Advice 9312; 2016 (css_9312_avis_Irr.pdf (french), hgr_9312_advies_rgr.pdf(dutch).

Ridker

Mora

Rose

. JUPITER Trial Study Group. Per cent reduction in LDL cholesterol following high-intensity statin therapy: Potential implications for guidelines and for the prescription of emerging lipid-lowering agents. Eur Heart J 2016; 37: 1373–1379.

10.

ANSES. Avis de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail relatif aux risques liés à la présence de « levure de riz rouge » dans les compléments alimentaires. Avis saisine n° 2012-SA-0228, https://www.anses.fr/fr/content/avis-de-l%E2%80%99anses-relatif-aux-risques-li%C3%A9s-%C3%A0-la-pr%C3%A9sence-de-%C2%AB-levure-de-riz-rouge-%C2%BB-dans-les (2014, accessed).

11.

Prescrire. Levure de riz rouge: Troubles musculaires et hépatiques. La Revue Prescrire 2015; 35: 18–18.

12.

Mazzanti

Moro

Rachi

et al.

Adverse reactions to dietary supplements containing red yeast rice: Assessment of cases from the Italian surveillance system. Br J Clin Pharm 2017; 83: 894–908.

13.

Philibert C, Bres V, Jean-Pastor MJ, et al. Atteintes musculaires et levure de riz rouge: Analyse des données de base nationale de pharmacovigilance et revue de la littérature. Therapie, https://dx-doi-org.web.bisu.edu.cn/10.2515/therapie/2015053 (2015, accessed).

14.

Mueller

. Symptomatic myopathy due to red yeast rice. Ann Intern Med 2006; 145: 474–475.